We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Popular Hip Prosthesis Show Long-Term Durability

By HospiMedica International staff writers
Posted on 10 Jan 2013
A new study that investigated the durability of Zweymüller hip prostheses has found that the stem of the endoprosthesis lasts for well over 20 years.

Researchers at the Medical University of Vienna (Austria) reported on the latest follow-up of the long-term results of 208 total hip replacements performed with the Zweymüller stem and a threaded cup in 200 patients, all with a minimum of 20 years postplacement; the report follows previous follow-ups conducted in 2002 and 2006. More...
In the present report, a total of 73 patients (75 hips) were available for follow-up, with a further 12 patients lost to follow-up since 2006. The main outcome measures were stem loosening and durability of the implant.

The results showed an absence of aseptic femoral stem loosening and a poor rate of survival of the threaded cup. The researchers observed osteolytic lesions around the proximal part of the femoral component on twenty-four (47%) of fifty-one radiographs, but no stem was deemed at risk for loosening. The probability of survival of the stem at twenty years was 0.96, and the probability of survival of the cup at twenty years was 0.67. The study was published in the September 2012 issue of the Journal of Bone and Joint Surgery.

“This shows that the fear over hip prostheses is unfounded. It is better to live with a prosthesis and without pain than to live without one and be in pain,” siad Reinhard Windhager, MD, head of orthopedics at the Medical University of Vienna.

The Zweymüller prosthesis, developed at the Medical University of Vienna by orthopedic surgeon Prof. Karl Zweymüller, MD, over 30 years ago, has a femoral stem with the shape of a tapered, rectangular implant, and was one of the first to be anchored in the bone without using bone cement for fixation, relying instead on the stem’s geometry and roughened surface features to provide stable anchoring and natural integration into the bone. While in the past the endoprosthesis was made from ultra-lightweight titanium, further revisions are now used in combination with a ball and socket made from ceramic, which produces less wear.

Related Links:
Medical University of Vienna


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.